1. Nivolumab versus everolimus in advanced renal-cell carcinoma;Motzer;N. Eng. J. Med.,2015
2. Cytoreductive nephrectomy in patients with metastatic renal cancer: a combined analysis;Flanigan;J. Urol.,2004
3. Cytoreductive nephrectomy in metastatic renal cell carcinoma treated with targeted therapies: a systematic review with a meta-analysis;Petrelli;Clin. Genitourin. Canc.,2016
4. Nivolumab vs Nivolumab + Bevacizumab vs Nivolumab + Ipilimumab in Metastatic Renal Cell Carcinoma (mRCC);ClinicalTrials.gov,2017
5. Nivolumab Combined With Ipilimumab Versus Sunitinib in Previously Untreated Advanced or Metastatic Renal Cell Carcinoma (CheckMate 214);ClinicalTrials.gov,2017